Edesa Biotech EPS misses by $0.04

Aug. 13, 2021 8:02 AM ETEdesa Biotech, Inc. (EDSA)By: Meghavi Singh, SA News Editor
  • Edesa Biotech (NASDAQ:EDSA): Q3 GAAP EPS of -$0.36 misses by $0.04.
  • There were no revenues for the three months ended June 30, 2021 compared to $0.11M for the three months ended June 30, 2020, reflecting the winddown and discontinuation of sales of product inventory from legacy operations.
  • Press Release
  • Cash and cash equivalents of $8.05M as of June 30, 2021.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.